Top GLP-1 Telehealth Programs in 2025

What Are GLP-1 Medications and Why Are They in Demand?

GLP-1 receptor agonists, such as semaglutide and tirzepatide, are a class of medications initially developed to help manage type 2 diabetes. These compounds mimic a naturally occurring hormone in the body called glucagon-like peptide-1 (GLP-1), which plays a key role in glucose metabolism. GLP-1 medications work by stimulating insulin secretion, reducing glucagon production, and slowing gastric emptying, all of which can contribute to improved blood sugar regulation when used as part of a provider-directed treatment plan.

In addition to their use in diabetes care, select branded versions, such as Wegovy® (semaglutide) and Zepbound® (tirzepatide), have received separate FDA approval for chronic weight management. These approvals are limited to adults with obesity, or those who are overweight and have at least one weight-related condition, such as high blood pressure, type 2 diabetes, or elevated cholesterol. These medications were approved following large-scale clinical trials in which participants received comprehensive care, including medical supervision and structured lifestyle interventions.

Although GLP-1 medications are not classified as weight loss drugs, clinical researchers have proposed that they may help support weight-related outcomes by modulating appetite, increasing satiety, and slowing digestion when used alongside dietary changes, physical activity, and ongoing care from a licensed provider. These potential mechanisms are still being studied and should not be viewed as a substitute for long-term lifestyle and behavior change. The clinical appropriateness and dosing of any GLP-1 medication must be determined by a licensed medical provider, based on a patient’s individual health profile and medical history.

One of the most pivotal studies supporting the FDA approval of semaglutide for chronic weight management is the STEP 1 clinical trial. This 68-week, randomized, placebo-controlled study assessed once-weekly semaglutide (2.4 mg) in adults with overweight or obesity who did not have type 2 diabetes. All participants received dietary counseling, were encouraged to set increased physical activity goals, and received routine medical supervision. On average, individuals treated with semaglutide lost 14.9% of their body weight, compared to 2.4% in the placebo group. These results were considered both statistically and clinically significant, directly contributing to the FDA approval of Wegovy® for weight management in eligible patients.

It is important to understand that these outcomes represent averages across a large clinical population. Individual results will vary, and several factors, including baseline health conditions, adherence to prescribed dosing, engagement in lifestyle changes, and the level of ongoing provider involvement, may influence weight loss. Patients considering GLP-1 therapy should speak with a licensed healthcare professional to evaluate whether this treatment is appropriate for their specific medical needs and wellness goals.

Ready to explore your GLP-1 treatment options?
Talk to a licensed provider and learn whether GLP-1 medications are appropriate for you.

Start Your Evaluation Today →

‍

What to Look for in a GLP-1 Telehealth Program

As interest in GLP-1 medications continues to rise, so does the number of telehealth platforms offering access to these treatments. However, not all programs are created equal. Patients should approach this decision with care, considering more than just the medication itself. A high-quality telehealth program prioritizes medical oversight, patient safety, and long-term support. Here are the key elements to look for:

Direct Access to Licensed Healthcare Professionals

Patients should have the ability to consult with licensed, independent medical providers, not just fill out a questionnaire or receive automated recommendations. Look for platforms that prioritize one-on-one virtual visits or messaging with real providers who can answer questions, explain treatment options, and tailor care based on your individual needs. Personalized care is especially important with GLP-1 medications, which often require ongoing monitoring and adjustments.

Evidence-Based Protocols Determined by Independent Providers

Treatment decisions should be made using current clinical guidelines and peer-reviewed research, not marketing trends. Platforms must give providers the autonomy to determine whether a patient qualifies for treatment based on their clinical profile, health history, and diagnostic criteria. Beware of services that promote “one-size-fits-all” dosing or promise results without medical evaluation, and these may be out of step with FDA guidance and best practices.

Follow-Ups and Dose Adjustments Made at the Provider’s Discretion

GLP-1 medications are not static treatments. Most patients require ongoing dose titration, symptom monitoring, and periodic reevaluation to manage side effects, optimize outcomes, and ensure the medication remains appropriate. A compliant program should include built-in follow-ups with the prescribing provider and flexibility to adjust the care plan over time based on your progress and tolerability.

Transparent Pricing and Terms

Look for platforms that clearly outline what is included in their service, such as provider consultations, medication costs, support tools, and follow-up visits, before you sign up. Avoid programs with hidden fees, unclear cancellation terms, or vague language around pharmacy charges. Transparency builds trust and helps you make informed decisions about your health and finances.

Optional Support Tools for Nutrition, Symptom Tracking, and Education

GLP-1 medications are most effective when paired with lifestyle changes, including better nutrition, increased movement, and long-term habit-building. Some telehealth platforms offer optional resources, such as access to registered dietitians, symptom-tracking apps, and evidence-informed educational content to help patients stay on track. While not required, these tools can significantly improve adherence and help patients feel more empowered throughout their treatment journey.

If a telehealth program lacks any of the above components, it may not be fully aligned with current medical standards or patient-centered care. Eden’s model connects patients to licensed providers who lead all treatment decisions and ensures that the process is guided by transparency, education, and individualized care, not shortcuts or unsupported claims.

Looking for care designed around your needs?
Eden helps you connect with licensed providers who can guide your next steps with a personalized approach.

Get Matched with a Provider →

‍

Platform Comparison

Eden

Overview: Eden is a digital health platform that connects patients with licensed, independent medical providers. These providers assess eligibility and may prescribe GLP-1 medications when clinically appropriate.

Support: Eden’s programs may include provider-directed care plans with optional access to symptom tracking, nutrition guidance, and lifestyle resources.

Flexibility: Providers determine medication type and dosing schedule based on each patient’s response and clinical profile.

Transparency: Eden offers upfront details on pricing, provider access, and what is included before signing up. Unlike some platforms that emphasize automatic renewals or one-size-fits-all protocols, Eden prioritizes transparency and individualization. Patients are guided through a step-by-step process that includes consultations with licensed providers, ensuring that any treatment decisions are medically appropriate and compliant with current clinical standards. No treatment is guaranteed; an independent, licensed healthcare professional determines eligibility.

Ro (Body Program)

Overview: Ro offers access to GLP-1 treatment through its Body Program.

Support: The program includes provider check-ins and health coaching.

Considerations: Some users report that communication and care customization may vary depending on provider availability and the specific care plan.

Henry Meds

Overview: Henry Meds offers access to GLP-1 medications, including compounded options.

Support:The platform focuses primarily on medication access. Limited public information is available on additional structured lifestyle tools or educational resources.

Important Note: The FDA currently does not list semaglutide as being in shortage at the time this article was written. As a result, the compounding of semaglutide outside of FDA-approved indications may not meet regulatory standards. Patients should consult with a licensed healthcare provider to understand their treatment options and verify that any medication they receive comes from a state-licensed pharmacy operating in compliance with FDA and state board regulations.

Other Competitors

• Hims & Hers: Offers provider access to GLP-1s. The level of support varies by plan.
  
• Fella Health: Focuses on men’s metabolic support with structured coaching. Services are primarily designed for male patients.
  
• LookMeds and Alan Meds: Smaller platforms with limited publicly available information about provider oversight and patient support.

Want a care experience built around your goals?
Take the first step with Eden and connect with a provider who understands your needs.

Start Your Evaluation Today →

‍

Conclusion

The GLP-1 telehealth landscape is evolving rapidly. While many platforms offer access to providers who may prescribe GLP-1 medications, not all place equal emphasis on transparency, provider involvement, or patient support. As interest in GLP-1 treatments grows, individuals should carefully evaluate service models and ensure that prescribing decisions remain with licensed providers who follow appropriate clinical guidelines.

Eden offers a simplified pathway to connect with independent, licensed medical providers who can evaluate eligibility for GLP-1 treatment. The platform emphasizes transparent pricing, provider-led care, and access to optional support tools.

For those exploring GLP-1 treatment options, Eden offers a convenient way to connect with licensed providers who can evaluate your needs and guide you through evidence-based care, all with clarity, discretion, and support tailored to your wellness goals.

This content is for informational purposes only and is not intended as medical advice. Eden does not prescribe medication, provide medical care, or manufacture drugs. Eden connects patients with licensed, independent medical providers who are solely responsible for all medical decisions, including diagnosis, treatment, and prescribing. Always consult with a licensed healthcare provider before beginning any treatment involving GLP-1 medications such as semaglutide or tirzepatide.

‍